ATC/DDD

ATC/DDD index G04CA

You are here: Home > ATC/DDD > G > G04 > G04C

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- G
GENITO URINARY SYSTEM AND SEX HORMONES
- G04
UROLOGICALS
- G04C
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY

G04CA

Alpha-adrenoreceptor antagonists

ATC/DDD code G04CA for Alpha-adrenoreceptor antagonists

Alfuzosin and terazosin used in the management of urinary obstruction caused by benign prostatic hypertrophy, are classified here, while other alpha-adrenoreceptor blocking agents used both in the management of urinary obstruction and hypertension (e.g. doxazosin) are classified in C02CA.

G04CA01
Alfuzosin
G04CA02
Tamsulosin
G04CA03
Terazosin
G04CA04
silodosin
G04CA51
alfuzosin and finasteride
G04CA52
tamsulosin and dutasteride
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us